 |
|
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
Sara Young, Enoch Chung, Michael A. Chen
Ann Geriatr Med Res. 2021;25(3):170-177. Published online 2021 Sep 29 DOI: https://doi.org/10.4235/agmr.21.0079
|
|
Citations to this article as recorded by
 Effects of different extraction methods on the structural characterization and bioactivities of polysaccharides extracted from Polygonatum sibiricum
Mao-Hui Yang, Xin Zhou, Yan Yang, Hua-Guo Chen
Journal of Food Measurement and Characterization.2024; 18(2): 940. CrossRef Galantamine-Induced Third-Degree Heart Block
Husam Katib, Amna Shah, Hamza Yousaf
Cureus.2024;[Epub] CrossRef Effect of caffeine-chitosan nanoparticles and α-lipoic acid on the cardiovascular changes induced in rat model of obesity
Eman N. Hosny, Hussein G. Sawie, Howida S. Abou-Seif, Yasser A. Khadrawy
International Immunopharmacology.2024; 129: 111627. CrossRef Mild hyperhomocysteinemia alters oxidative stress profile via Nrf2, inflammation and cholinesterases in cardiovascular system of aged male rats
Gustavo Ricardo Krupp Prauchner, Osmar Vieira Ramires Junior, Alessandra Schmitt Rieder, Angela T.S. Wyse
Chemico-Biological Interactions.2024; 396: 111028. CrossRef Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher
Pharmaceutics.2023; 15(3): 916. CrossRef Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated
Raffaele Pagliuca, Mario Virgilio Papa, Pagliuca Mena Ilaria, Virginia Federica Papa, Gina Varricchio
Annals of Geriatric Medicine and Research.2023; 27(1): 83. CrossRef Pacemaker Implants and Their Influence on the Daily Life of Patients with Dementia with Lewy Bodies: A Qualitative Case Study
Isak Heyman, Annika Brorsson, Torbjörn Persson, Elisabet Londos
Neurology and Therapy.2023; 12(4): 1359. CrossRef Guidelines for pharmacotherapy in Alzheimer’s disease – A primer on FDA-approved drugs
Ashvin Varadharajan, Aarjith Damian Davis, Aishwarya Ghosh, Tejaswini Jagtap, Anjo Xavier, Anjana Jayakumar Menon, Dwaiti Roy, Sandhya Gandhi, Thomas Gregor
Journal of Neurosciences in Rural Practice.2023; 14: 566. CrossRef Peptidomimetics based on ammonium decasubstituted pillar[5]arenes: Influence of the alpha-amino acid residue nature on cholinesterase inhibition
Anastasia Nazarova, Pavel Padnya, Alexandra Kharlamova, Konstantin Petrov, George Yusupov, Pavel Zelenikhin, Mikhail Bukharov, Bin Hua, Feihe Huang, Ivan Stoikov
Bioorganic Chemistry.2023; 141: 106927. CrossRef Cholinesterase inhibitors associated with lower rate of mortality in dementia patients with heart failure: a nationwide propensity weighting study
Ming-Jer Hsieh, Cheng-Hung Lee, Dong-Yi Chen, Chia-Ling Wu, Yu-Tung Huang, Shang-Hung Chang
Clinical Autonomic Research.2023; 33(6): 715. CrossRef Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4‐oxadiazole derivatives
Şeyma Durmaz, Asaf E. Evren, Begüm N. Sağlık, Leyla Yurttaş, Naime F. Tay
Archiv der Pharmazie.2022;[Epub] CrossRef
|